Literature DB >> 23003681

Evaluation of sexual function in patients presenting with Behçet's disease with or without depression.

I G Gül1, Ş Kartalcı, B E Cumurcu, Y Karıncaoğlu, S Yoloğlu, R Karlıdağ.   

Abstract

AIM: Sexual dysfunction has been found in many disorders that are chronic or disabling. The aim of this study was to evaluate the sexual satisfaction levels, sexual function and their relationship with the mental state in a group of patients being followed-up with a diagnosis of Behçet's disease (BD).
METHOD: A total of 50 BD patients and 50 control-group subjects were administered the Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Golombok Rust Sexual Satisfaction Scale (GRISS) and Arizona Sexual Experiences Scale (ASEX).
RESULTS: The ASEX, GRISS total, HDRS and HARS scores were significantly higher in the patient group than the control subjects (P = 0.0001, P = 0.007, P = 0.0001, P = 0.0001 respectively). Sexual dissatisfaction was seen in 40 (80%) of the patient-group and 16 (32%) of the control-group subjects according to the GRISS (P = 0.0001). Female study participants had higher mean scores than the control subjects for the ASEX, GRISS total scores and the GRISS satisfaction, avoidance, vaginismus and orgasm subscale scores (P = 0.0001, P = 0.002, P = 0.02, P = 0.001, P = 0.006, P = 0.03 respectively). Male study participants had different mean scores for the controls regarding the ASEX scores and the GRISS impotence, premature ejaculation, satisfaction and frequency subscale scores (P = 0.01, P = 0.01, P = 0.0001, P = 0.03, P = 0.007 respectively). DISCUSSION: The negative effect of the disorder on the biological and functional status and daily living activities in BD patients also influences the patients' sexual experiences and satisfaction. The negative effects of chronic diseases such as BD should therefore be defined and the disorder evaluated from a wide perspective during the treatment process.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2012        PMID: 23003681     DOI: 10.1111/j.1468-3083.2012.04698.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

Review 1.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

2.  Identification of physical and psychosocial problems based on symptoms in patients with Behçet's disease.

Authors:  Hideyo Tsutsui; Hirotoshi Kikuchi; Hiroko Oguchi; Kyoko Nomura; Takayoshi Ohkubo
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

3.  Sexual dysfunction in Behçet's syndrome.

Authors:  Rosaria Talarico; Elena Elefante; Alice Parma; Fabio Taponeco; Tommaso Simoncini; Marta Mosca
Journal:  Rheumatol Int       Date:  2019-10-08       Impact factor: 2.631

4.  Genital ulcer severity score and genital health quality of life in Behçet's disease.

Authors:  Amal Senusi; Noha Seoudi; Lesley Ann Bergmeier; Farida Fortune
Journal:  Orphanet J Rare Dis       Date:  2015-09-22       Impact factor: 4.123

Review 5.  Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes.

Authors:  Joanna C Robson; David Jayne; Peter A Merkel; Jill Dawson
Journal:  Patient Relat Outcome Meas       Date:  2019-02-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.